Impact of solvent/detergent treatment of plasma on transfusion-relevant bacteria

Vox Sanguinis

Volumn 102, Issue 4, 2012, Pages 277-284

  Chou, M L ^a   Wu, Y W ^a   Su, C Y ^b   Lee, L W ^a   Burnouf, T ^a,c  

^a TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^b NATIONAL YANG MING UNIVERSITY   (Taiwan)

^c HUMAN PROTEIN PROCESS SCIENCES   (France)

Author keywords

Blood establishments; Filtration; Plasma; Solvent detergent; Viral inactivation

Indexed keywords

COMPLEMENT; DETERGENT; OCTOXINOL; PHOSPHATE BUFFERED SALINE; SOLVENT; TRIBUTYL PHOSPHATE;

APHERESIS; ARTICLE; BACILLUS CEREUS; BACILLUS SUBTILIS; BACTERIAL COUNT; BACTERIAL GROWTH; BACTERICIDAL ACTIVITY; CONTROLLED STUDY; ENTEROBACTER CLOACAE; ESCHERICHIA COLI; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; HUMAN; KLEBSIELLA PNEUMONIAE; NONHUMAN; PLASMA; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS EPIDERMIDIS; TRANSFUSION;

BACTERIA; BLOOD TRANSFUSION; COMPLEMENT SYSTEM PROTEINS; DETERGENTS; GRAM-NEGATIVE BACTERIA; HUMANS; PLASMA; SOLVENTS;

EID: 84859853766     PISSN: 00429007     EISSN: 14230410     Source Type: Journal    
DOI: 10.1111/j.1423-0410.2011.01560.x     Document Type: Article

References (26)

1. Horowitz B, Wiebe ME, Lippin A, et al. : Inactivation of viruses in labile blood derivatives. I. Disruption of lipid-enveloped viruses by tri(n-butyl)phosphate detergent combinations. Transfusion 1985; 25:516-522
2. Horowitz B, Bonomo R, Prince AM, et al. : Solvent/detergent-treated plasma: a virus-inactivated substitute for fresh frozen plasma. Blood 1992; 79:826-831
3. Dichtelmuller HO, Biesert L, Fabbrizzi F, et al. : Robustness of solvent/detergent treatment of plasma derivatives: a data collection from Plasma Protein Therapeutics Association member companies. Transfusion 2009; 49:1931-1943
4. Burnouf T, Radosevich M: Reducing the risk of infection from plasma products: specific preventative strategies. Blood Rev 2000; 14:94-110
5. Prowse C: Properties of pathogen-inactivated plasma components. Transfus Med Rev 2009; 23:124-133
6. WHO: Guidelines on Viral Inactivation and Removal Procedures Intended to Assure the Viral Safety of Human Blood Plasma Products. Geneva, WHO, 2003; (last accessed 9 November 2011)
7. de Korte D, Marcelis JH, Soeterboek AM: Determination of the degree of bacterial contamination of whole-blood collections using an automated microbe-detection system. Transfusion 2001; 41:815-818
8. Blajchman MA, Beckers EA, Dickmeiss E, et al. : Bacterial detection of platelets: current problems and possible resolutions. Transfus Med Rev 2005; 19:259-272
9. Blajchman MA: Bacterial contamination of cellular blood components: risks, sources and control. Vox Sang 2004; 87(Suppl 1):98-103
10. Montag T: Strategies of bacteria screening in cellular blood components. Clin Chem Lab Med 2008; 46:926-932
11. Jenkins C, Ramirez-Arcos S, Goldman M, et al. : Bacterial contamination in platelets: incremental improvements drive down but do not eliminate risk. Transfusion 2011; DOI: 10.1111/j.1537-2995.2011.03187.x
12. Pietersz RN, Engelfriet CP, Reesink HW, et al. : Detection of bacterial contamination of platelet concentrates. Vox Sang 2007; 93:260-277
13. Schrezenmeier H, Walther-Wenke G, Muller TH, et al. : Bacterial contamination of platelet concentrates: results of a prospective multicenter study comparing pooled whole blood-derived platelets and apheresis platelets. Transfusion 2007; 47:644-652
14. Burns KH, Werch JB: Bacterial contamination of platelet units: a case report and literature survey with review of upcoming american association of blood banks requirements. Arch Pathol Lab Med 2004; 128:279-281
15. Walther-Wenke G, Schrezenmeier H, Deitenbeck R, et al. : Screening of platelet concentrates for bacterial contamination: spectrum of bacteria detected, proportionof transfused units, and clinical follow-up. Ann Hematol 2010; 89:83-91
16. Jezkova Z: Frozen human plasma and bacterial contamination. Blut 1972; 25:249-254
17. Buchta C, Dettke M, Funovics PT, et al. : Impact of manufacturing, irradiation and filtration steps to bacterial contamination of autologous fibrin sealant. Biologicals 2004; 32:165-169
18. Kessler HJ, Redmann U: Experience with low temperature storage of bacteria and fungi. Infection 1974; 2:29-36
19. Wagner SJ, Friedman LI, Dodd RY: Transfusion-associated bacterial sepsis. Clin Microbiol Rev 1994; 7:290-302
20. El-Ekiaby M, Sayed MA, Caron C, et al. : Solvent-detergent filtered (S/D-F) fresh frozen plasma and cryoprecipitate minipools prepared in a newly designed integral disposable processing bag system. Transfus Med 2010; 20:48-61
21. CPMP: Note for Guidance on Virus Validation Studies: The Design, Contribution and Interpretation of Studies Validating the Inactivation and Removal of Viruses (Revised). CPMP/BWP/CPMP/5136/03. London, European Agency for the Evaluation of Medicinal Products (EMEA), 1996. (last accessed 9 November 2011)
22. Mohr H, Bayer A, Gravemann U, et al. : Elimination and multiplication of bacteria during preparation and storage of buffy coat-derived platelet concentrates. Transfusion 2006; 46:949-955
23. Hogman CF, Gong J, Eriksson L, et al. : White cells protect donor blood against bacterial contamination. Transfusion 1991; 31:620-626
24. Stormer M, Vollmer T, Kleesiek K, et al. : Spore-forming organisms in platelet concentrates: a challenge in transfusion bacterial safety. Transfus Med 2008; 18:371-376
25. Stormer M, Arroyo A, Brachert J, et al. : Establishment of the first International repository for transfusion-relevant bacteria reference strains: ISBT Working Party Transfusion-Transmitted Infectious Diseases (WP-TTID), subgroup on bacteria. Vox Sang 2011; DOI: 10.1111/j.1423-0410.2011.01510.x
26. Benjamin RJ, Wagner SJ: The residual risk of sepsis: modeling the effect of concentration on bacterial detection in two-bottle culture systems and an estimation of false-negative culture rates. Transfusion 2007; 47:1381-1389